What is the upside for OraSure Technologies (Ora) stock?
Their forecasts range from $12.50 to $20.00. On average, they expect OraSure Technologies' share price to reach $15.83 in the next twelve months. This suggests a possible upside of 67.4% from the stock's current price. View analysts' price targets for OraSure Technologies or view top-rated stocks among Wall Street analysts.
When is OraSure Technologies'next quarterly earnings announcement?
OraSure Technologies is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022. View our earnings forecast for OraSure Technologies. How were OraSure Technologies' earnings last quarter?
How well has OraSure Technologies performed in research reports?
OraSure Technologies has only been the subject of 2 research reports in the past 90 days. OraSure Technologies has received 538 “outperform” votes. (Add your “outperform” vote.)
When is OraSure's 2022 annual meeting of stockholders?
BETHLEHEM, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2022 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 17, 2022. The record date for the Meeting will be March 27, 2022.
Is OraSure publicly traded?
OraSure Technologies' stock was trading at $8.69 at the beginning of 2022. Since then, OSUR stock has decreased by 65.1% and is now trading at $3.03.
Should I buy OraSure Technologies stock?
The financial health and growth prospects of OSUR, demonstrate its potential to perform inline with the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D.
Will OSUR stock go up?
The 4 analysts offering 12-month price forecasts for OraSure Technologies Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +157.35% increase from the last price of 2.72.
When did OraSure go public?
June 01, 2020June 01, 2020 16:01 ET | Source: OraSure Technologies, Inc. OraSure Technologies, Inc. BETHLEHEM, Pa., June 01, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced it has commenced an underwritten public offering of 8,000,000 shares of its common stock.
Who owns OraQuick?
Manufacturer: OraSure Technologies, Inc.
Who manufactures OraQuick?
OraQuick is an at-home HIV test manufactured by Orasure Technologies that was approved by the United States Food and Drug Administration in 2012.
How accurate is Intelliswab?
Additionally, the InteliSwab™ COVID-19 Rapid Test Pro correctly identified 98% of negative samples.
Should I buy or sell OraSure Technologies stock right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last twelve months. There are currently 1 hold...
What is OraSure Technologies' stock price forecast for 2022?
3 brokerages have issued 12 month price objectives for OraSure Technologies' shares. Their forecasts range from $10.00 to $14.00. On average, they...
How has OraSure Technologies' stock performed in 2022?
OraSure Technologies' stock was trading at $8.69 on January 1st, 2022. Since then, OSUR shares have decreased by 68.6% and is now trading at $2.73....
When is OraSure Technologies' next earnings date?
OraSure Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022. View our earnings forecast for...
How were OraSure Technologies' earnings last quarter?
OraSure Technologies, Inc. (NASDAQ:OSUR) posted its quarterly earnings results on Tuesday, May, 10th. The medical instruments supplier reported ($0...
Who are OraSure Technologies' key executives?
OraSure Technologies' management team includes the following people: Dr. Nancy J. Gagliano M.B.A. , M.D., Interim CEO & Director (Age 62, Pay $8...
What is Stephen Tang's approval rating as OraSure Technologies' CEO?
2 employees have rated OraSure Technologies CEO Stephen Tang on Glassdoor.com . Stephen Tang has an approval rating of 100% among OraSure Technolo...
Who are some of OraSure Technologies' key competitors?
Some companies that are related to OraSure Technologies include West Pharmaceutical Services (WST) , Align Technology (ALGN) , Cooper Companies...
What other stocks do shareholders of OraSure Technologies own?
Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical S...
About OraSure Technologies
OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices.
Nasdaq Global Select
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock.
Environmental, Social, and Governance Rating
The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
What is Orasure Technologies?
The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.
Where is Orasure Technologies located?
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, Diagnostics and Molecular Solutions.
What is Orasure technology?
OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
Does Morningstar cover ratings?
OraSure Technologies Inc is engaged in the development, manufacturing, and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its reportable segments are Diagnostics business which consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Molecular Solutions business that manufactures and sells kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing.
